Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Oncocyte Corporation Common Sto

TRADE

AMEX: OCXHealthcare / Diagnostic Substances / California, U.S.A
3.10-0.10-3.13%Vol 30 9161Y Perf -27.91%
Jul 20th, 2018 16:00
BID3.00 ASK3.15
Open3.25 Previous Close3.20
Pre-Market- After-Trading-
 - -%  - -%
Target Price
4.42 
Analyst Rating
Moderate Buy 1.67
Potencial %
42.58 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/100/100 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/100/100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/100/100 
Income Ranking
 —    -
Market Cap (mil)122 
Earnings Rating
Neutral
Price Range Ratio 52wk %
30.58 
Earnings Date
13th Aug 2018

Today's Price Range

3.053.25

 

52wk Range

1.107.64

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Sell
Performance
1 Month
34.78%
3 Months
26.53%
6 Months
-26.19%
1 Year
-27.91%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
OCX3.10-0.1000-3.13
AAPL191.44-0.4400-0.23
GOOG1 184.91-2.0500-0.17
MSFT106.271.87001.79
XOM81.40-0.6100-0.74
WFC56.410.08000.14
JNJ125.85-0.0900-0.07
FB209.941.85000.89
GE13.12-0.6100-4.44
JPM111.281.39001.26
...

TickerPriceChg.%52 Week High
CTAS203.575.11204.27
PM84.314.22120.00
VFC92.944.1593.51
HON153.133.79165.13
SWK144.233.28176.62
PDCO23.642.8743.20
DOV80.242.7188.11
STI70.842.6473.37
ADS233.082.59278.33
NUE66.252.4470.48
KSU111.052.40114.91
IDXX248.142.19248.65
COF97.231.95106.50
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 2.50
Current Ratio 2.60
Long Term Debt to Total Capital 0.11
Total Debt to Equity 0.25
Interest Coverage -306.50
Leverage Ratio 1.90
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 13.76
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -12.90
Cash Flow Per Share -0.42
Price to Tangible Book14.89
Book Value per Share0.23
Enterprise Value (in ths.)112 803
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-170.09
ROE last 12 Months -192.43
Return on Assets (5Y Avg) -61.70
ROA last 12 Months -111.33
Return on Capital (5Y Avg) -131.36
ROC last 12 Months -164.57
Return on invested Capital Q -40.94
Return on invested Capital Y-224.33
Assets Turnover0.00
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)0
Revenue per Share 0.00
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2018-0.13-0.127.69
Q04 2017--0.13-
Q03 2017-0.13-0.127.69
Q02 2017-0.12-0.13-8.33
Q01 2017-0.13-0.16-23.08
Q04 2016-0.10-0.11-10.00
Q03 2016-0.10-0.100.00
Q02 2016-0.11-0.109.09
Earnings Per EndEstimateRevision %Trend
6/2018 QR-0.1080.00Positive
9/2018 QR-0.0983.64Positive
12/2018 FY-0.40--
12/2019 FY-0.45--
Next Report Date13th Aug 2018
Estimated EPS Next Report-0.10
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume30 916
Shares Outstanding (in ths.)39 400
Trades Count108
Dollar Volume93 767
Avg. Volume82 832
Avg. Weekly Volume69 148
Avg. Monthly Volume214 762
Avg. Quarterly Volume99 170

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

33%67%

Bearish Bullish

45%55%

Bearish Bullish

63%37%

Bearish Bullish

68%32%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (66.67 %)
2 (66.67 %)
2 (66.67 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (33.33 %)
1 (33.33 %)
1 (33.33 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.67
Moderate Buy
1.67
Moderate Buy
1.67

There are no comments yet.

News

x